In other industry news:
Special life sciences advisory firm, SkilaMederi has announced a new appointment to its Executive Management Team as Raymond Joske becomes Chief Commercial Officer.
Joske has worked at Bristol-Myers Squibb and Merck in his 28 years in the life sciences industry.
CEO Kilian Weiss said: "We look forward to his contribution as SkilaMederi embarks on this next stage of growth."
CRO PPD has announced three new Therapeutic Heads in its expansion of its global product department. Drs. Daniel J. Burch, Puneet Mohan and Alan M. Solinger all join the team in the areas of central nervous system, cardiovascular and rheumatology/immunology respectively.
Each head will play key roles in addressing critical drug development challenges.
The latest faces in drug discovery, CROs, and research charities.
Results from the 50 Most Influential People in Vaccines, Aligent changes CEOs, and more...
On the eve of the historical vote on Scottish independence from the UK tomorrow, we take a...
New execs for ICON and PPD, plus services shake-ups in this week's column.